CécileCouchoud FranceREIN registry, Agence de la biomédecine, France

• Predicting the Risks of Kidney Failure and Death in Adults With Moderate-to-severe Chronic Kidney Disease (KDpredict)
  PietroRavani Free Communication pravani@ucalgary.caCanadaUniversity of Calgary
• Plasma Exchange in ANCA Associated Vasculitis GN: Update After Pexivas
  Wladimir MietekSzpirt Speaker wladimir.mietek.szpirt.01@regionh.dkDenmarkRigshospitalet, University of Copenhagen, Dept. of Nephrology, Denmark, Senior Research Consultant
• EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY: INTERIM RESULTS FROM THE PHASE 3 APPLAUSE-IgAN STUDY
  DanaRizk Free Communication drizk@uabmc.eduUnited StatesUniversity of Alabama at Birmingham
• SPARSENTAN VS IRBESARTAN IN PATIENTS WITH IMMUNOGLOBULIN A NEPHROPATHY (IgAN): SUBGROUP ANALYSES OF 2-YEAR RESULTS FROM THE PIVOTAL PHASE 3 PROTECT TRIAL
  Jonathan Barratt Free Communication jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK
• PREGNANCY AMONG WOMEN ON CHRONIC DIALYSIS : THE FRENCH COHORT
  CécileCouchoud Free Communication cecile.couchoud@biomedecine.frFranceREIN registry, Agence de la biomédecine, France